AzTrials
AzTrials

Femoral Neck FracturesPhase 1NCT01109862

Prospective Randomized Comparison of Bipolar Hemiarthroplasty and Total Hip Arthroplasty With Large Femoral Heads for the Treatment of Displaced Intracapsular Femoral Neck Fractures in the Elderly

A Phase 1 study testing Total hip arthroplasty and Hemiarthroplasty in people with Femoral Neck Fractures, run by Wolfson Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare hemiarthroplasty (HAP) with total hip arthroplasty (THA), performed by trained arthroplasty surgeons with the use of large femoral heads for the treatment of displaced femoral neck fractures in mobile independent elderly patients, to determine the impact of these surgical… Read more about this study

Who is it for?
Ages 70 to 90 years
Conditions the study is for
Femoral Neck Fractures
What is being tested?
Total hip arthroplasty and Hemiarthroplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteIsrael
Study dates
Apr 2010to Dec 2013
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 to 90 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • 1. Acute femoral neck fracture.
  • 2. Age between 70 and 90 years old.
  • 3. Independent community ambulator (more than 0.5km, without the aid of another person. The use of a cane is permitted) prior to fracture.
  • 4. Abbreviated mental test score > 6 .

Who cannot join

  • 1. Pathological fracture (excluding osteoporosis).
  • 2. Rheumatoid arthritis.
  • 3. Symptomatic arthrosis of the involved hip.
  • 4. Neurological disorder that may significantly influence walking ability and/or tendency to dislocate.
  • 5. Chronic corticosteroid use.
  • 6. Concomitant other fracture.
  • 7. Very high surgical risk.

Trial locations and contacts

1 site in 1 country.

Dror Lakstein, MD contact

++972-3-5028383

drorale@gmail.com

Israel1 site, 1 recruiting
  • Orthopaedic dept., E. Wolfson Medical center

    Holon, 58100

    Dror Lakstein, MD, ++972-3-5028383, drorale@gmail.com

    Recruiting

Other trials in Israel

About this study

The purpose of this study is to compare hemiarthroplasty (HAP) with total hip arthroplasty (THA), performed by trained arthroplasty surgeons with the use of large femoral heads for the treatment of displaced femoral neck fractures in mobile independent elderly patients, to determine the impact of these surgical options on the short term functional outcomes and complication rates, namely dislocation and the need for further surgery.

This is a single-blinded prospective randomized clinical trial comparing functional outcome and complication rates of 40 patients treated with all cemented THA to a control group of 40 patients treated with cemented bipolar HAP, in a 2 years followup.

The primary endpoint is the Oxford hip score (OHS) at last followup as a measure of functional outcome. Secondary endpoints include the SF-36 score, walking distance and rates of postoperative dislocation, component loosening, need for revision and postoperative mortality.

Being tested
Total hip arthroplasty, Hemiarthroplasty
Keywords
Femoral neck fractures, Hip fractures, Elderly, Total hip arthroplasty, Bipolar hemiarthroplasty
Medical subject headings
Femoral Neck Fractures, Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total hip arthroplastyProcedure or surgery

    All cemented THA

  • HemiarthroplastyProcedure or surgery

    Cemented bipolar HAP

Study groups in NCT01109862
Study groupRoleWhat they receive
THAExperimentalTotal hip arthroplasty
Receives: Procedure: Total hip arthroplasty
HAPActive comparatorBipolar Hemiarthroplasty
Receives: Procedure: Hemiarthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxford hip score (OHS)

    Measured: last followup - 2 years

Secondary outcomes (2)
  1. SF-36 score, walking distance

    Measured: 2 years followup

  2. dislocation rate, mortality rate

    Measured: within follow up - 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2010 (estimated)
  2. Study startApr 2010
  3. Primary completionJun 2013 (estimated)
  4. Study completionDec 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01109862
Sponsor's protocol ID
0019-10-WOMC
Status last verified
Apr 2010
First submitted
22 Apr 2010
Last updated
17 Jun 2011
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Total hip arthroplasty and Hemiarthroplasty in people with Femoral Neck Fractures, run by Wolfson Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dror Lakstein, MD (++972-3-5028383, drorale@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxford hip score (OHS) (time frame: last followup - 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in